Prescription drug · ANDA
Pitolisant NDC 70748-386
Pitolisant hydrochloride 4.45 mg/1 · Tablet, Film coated · Oral · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70748-386-01 | 7074803860170748038601 | 1 BOTTLE in 1 CARTON (70748-386-01) / 30 TABLET, FILM COATED in 1 BOTTLEMarketed from Oct 16, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Pitolisant
- Generic name (nonproprietary)
- pitolisant
- Active ingredients
- Pitolisant hydrochloride — 4.45 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals, Inc.NDC labeler code 70748
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218846
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 3A4 Inducers (Mechanism)Histamine H3 Receptor Antagonists (Mechanism)Histamine H3 Receptor Inverse Agonists (Mechanism)
- Identifiers
- Product ID 70748-386_e46eef01-594a-49ca-a453-0b680e4ee730SPL ID e46eef01-594a-49ca-a453-0b680e4ee730SPL set ID 6fb94d86-5154-4b69-8470-d1145d426312RxCUI 2197884, 2197892UNII YV33CH63HIUPC 0370748386019, 0370748387016
- Pharmacologic class
- Histamine-3 Receptor Antagonist/Inverse Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470748038601followed by a unit qualifier and the quantityPackage 70748-0386-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Pitolisant Tablets are indicated for the treatment of excessive daytime sleepiness (EDS) in patients with narcolepsy . Pediatric use information is approved for Harmony Biosciences Management Inc.'s WAKIX (pitolisant) tablets. However, due to Harmony Biosciences Management Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. Pitolisant tablets are histamine-3 (H3) receptor antagonist/inverse agonist indicated for the treatment of excessive daytime sleepiness (EDS) in patients with narcolepsy ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70748-386
- What is NDC 70748-386?
- 70748-386 is the product NDC for Pitolisant, Pitolisant hydrochloride 4.45 mg/1 tablet, film coated, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Pitolisant.
- What is the active ingredient?
- Pitolisant hydrochloride.
- Who is the labeler?
- Lupin Pharmaceuticals, Inc., NDC labeler code 70748. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Pitolisant?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 218846
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Pitolisant | Pitolisant hydrochloride 17.8 mg/1 | Tablet, Film coatedOral | Lupin Pharmaceuticals, Inc. | 70748-387 |